Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Uterine Tubes01:16

Uterine Tubes

2.3K
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025.

Geburtshilfe und Frauenheilkunde·2026
Same author

Diagnosis and Therapy of Endometriosis. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/045, April 2025).

Geburtshilfe und Frauenheilkunde·2026
Same author

Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study.

Gynecologic oncology·2025
Same author

Evaluation of Baseline Characteristics and Therapeutic Management Strategies in Metastatic Cervical Cancer in Germany: A Multicentric Retrospective Longitudinal Observational Study: A Quality Assurance Initiative of the AGO-Study Group and AGO-OK Uterus.

Geburtshilfe und Frauenheilkunde·2025
Same author

Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Same author

Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024).

Geburtshilfe und Frauenheilkunde·2025
Same journal

Efficacy of Honey Combined with Cryotherapy in the Prevention and Management of Radiation-Induced Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Head and Neck Cancer.

Oncology research and treatment·2026
Same journal

Three therapeutic modalities for advanced ovarian cancer: real world data from a certified oncological center.

Oncology research and treatment·2026
Same journal

Real world experiences in the treatment of immune thrombocytopenia over a two-year period.

Oncology research and treatment·2026
Same journal

Safety and preliminary activity of neoadjuvant trastuzumab deruxtecan (T-DXd) plus 5-fluorouracil and folinic acid for HER2-positive, resectable esophagogastric adenocarcinoma: Results from the safety run-in cohort of the phase Ib/II UCCL-AIO-STO0124-IKF072 NeoART trial.

Oncology research and treatment·2026
Same journal

Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-invasive Bladder Cancer.

Oncology research and treatment·2026
Same journal

The Role of Regulatory Policies in Shaping Outpatient Cancer Treatment in Germany: A Comparative Perspective.

Oncology research and treatment·2026
See all related articles

Related Experiment Video

Updated: Feb 3, 2026

Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions
08:07

Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions

Published on: May 26, 2023

1.9K

Uterine Adenosarcoma.

Uwe A Ulrich, Dominik Denschlag

    Oncology Research and Treatment
    |October 17, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Uterine adenosarcoma is a rare cancer. While typically low-grade, sarcomatous overgrowth indicates aggressive behavior and requires surgical treatment, with chemotherapy and endocrine therapy as potential options for recurrence.

    Keywords:
    Gynecological malignancySarcomaUterine adenosarcoma

    More Related Videos

    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
    04:08

    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

    Published on: June 27, 2025

    1.1K
    Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue
    08:02

    Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue

    Published on: January 6, 2012

    29.8K

    Related Experiment Videos

    Last Updated: Feb 3, 2026

    Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions
    08:07

    Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions

    Published on: May 26, 2023

    1.9K
    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
    04:08

    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

    Published on: June 27, 2025

    1.1K
    Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue
    08:02

    Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue

    Published on: January 6, 2012

    29.8K

    Area of Science:

    • Gynecologic Oncology
    • Pathology
    • Surgical Oncology

    Background:

    • Uterine adenosarcoma is a rare biphasic malignancy.
    • Characterized by sarcomatous stroma and benign epithelium.
    • Sarcomatous overgrowth (>25% tumor volume) signifies aggressive behavior.

    Purpose of the Study:

    • To summarize the characteristics, prognosis, and treatment of uterine adenosarcoma.
    • To highlight the implications of sarcomatous overgrowth.
    • To discuss management strategies for primary and recurrent disease.

    Main Methods:

    • Review of existing literature on uterine adenosarcoma.
    • Analysis of prognostic factors, including sarcomatous overgrowth.
    • Evaluation of current treatment modalities and outcomes.

    Main Results:

    • Uterine adenosarcomas are typically low-grade but can exhibit aggressive behavior with sarcomatous overgrowth.
    • Stage I uterine adenosarcoma without sarcomatous overgrowth has an 80% 5-year survival rate.
    • Complete surgical resection is the primary treatment; adjuvant therapies are not standardized.

    Conclusions:

    • Complete surgical removal is crucial for uterine adenosarcoma.
    • Recurrent or metastatic disease management requires further research into optimal chemotherapy and endocrine therapy.
    • Distinguishing between adenosarcoma and adenosarcoma with sarcomatous overgrowth is critical for patient management and prognosis.